Expert Opinion on Therapeutic Targets

Papers
(The H4-Index of Expert Opinion on Therapeutic Targets is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy80
Potential role of indole-3-propionic acid in tuberculosis: current perspectives and future prospects57
CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectives46
Targeting transcription in neuroblastoma: focus on the core regulatory circuit45
Interleukin-18 in cancer immunology and immunotherapy44
Calcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCA44
IL-36: a therapeutic target for ulcerative colitis?39
The clinical and immunological features of alopecia areata following SARS-CoV-2 infection or COVID-19 vaccines39
Mitochondrial permeability transition pore: a snapshot of a therapeutic target38
Emergent RNA targets in cardiovascular disease: likely candidates for treatment development38
P2 receptors as emerging therapeutic targets in neglected parasitic diseases33
Glycoproteins and longevity: an interview with Professor Gordan Lauc30
Molecular basis for targeting TBK1 in CAR-T cell therapies for cancer28
The membrane receptor CD44: roles in neurodegenerative diseases27
Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement26
The sigma–1 receptor: a mechanistically–informed therapeutic target for antidepressants25
The potential of multimolecular G-quadruplex structures for targeted treatment of Amyotrophic Lateral Sclerosis24
Identification of target sites in the VHR (DUSP3) enzyme unlocking potential avenues for future sepsis treatment23
Blocking glycan production by targeting GALNT7 for prostate cancer therapy22
The role of human complement factor H in retinal immune response and the prospects for targeted therapy for age-related macular degeneration (AMD)22
Kallikrein-related peptidases: mechanistic understanding for potential therapeutic targeting in cancer22
Advances in CGRP therapeutic targets for migraine: where do we stand 5 years later?22
Current challenges in the discovery of treatments against Mayaro fever22
Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets22
MDA-9/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understanding22
0.48236894607544